BNGO.NASDAQBionano Genomics, INC

4/A: Bionano COO Mark Oldakowski's RSU Tax Withholding

Sentiment:

Insider Transaction Disclosure

📋All filings for Bionano Genomics, INC
🔒Login to Follow

Bionano Genomics' COO, Mark Oldakowski, reported the withholding of 59 common shares for tax obligations related to a vested RSU award.

Summary

  • Mark Oldakowski, Chief Operating Officer of Bionano Genomics, Inc. (BNGO), reported a transaction involving company common stock.
  • On September 11, 2025, 59 shares of common stock were withheld by the issuer.
  • This withholding was to satisfy tax obligations upon the settlement of a Restricted Stock Unit (RSU) award.
  • The RSU award was originally granted on September 11, 2023, and vested on September 11, 2025.
  • The deemed price for the withheld shares was $4.06 per share.
  • Following this transaction, Mr. Oldakowski beneficially owns 915 shares of common stock directly.

Sentiment

Score: 5

Explanation: Neutral. This is a routine, expected insider transaction for tax purposes upon RSU vesting, with no material impact on the company's operations or financial health.

Positives

  • Vesting of 59 shares from an RSU award for COO Mark Oldakowski, indicating compensation realization.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4/A filing.

Industry Context

This filing is a routine disclosure of an insider's equity compensation transaction and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

  • Shareholders: Minimal direct impact as this is a small, routine transaction related to executive compensation.
  • Employees: The vesting of RSUs is a positive for the Chief Operating Officer as it represents realized compensation.

Key Dates

DateDescription
09/11/2023Date RSU award was granted.
09/11/2025Date RSU award vested and shares were withheld for tax obligations (also the earliest transaction date reported).
09/12/2025Date of original Form 4 filing (which this 4/A amends) and the signature date of this Form 4/A.

Keywords

Bionano Genomics, BNGO, Mark Oldakowski, Chief Operating Officer, COO, SEC Form 4/A, Insider Transaction, Restricted Stock Units, RSU, Tax Withholding, Equity Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.